An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3
Clinical trial NCT00000747 · COMPLETED
Trial details
- NCT number
- NCT00000747
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 1994-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.